PONATINIB EXPERIENCE IN A PEDIATRIC CHRONIC MYELOID LEUKEMIA PATIENT

Objective: Chronic myeloid leukemia (CML) is rarely seen in children. The development of myelofibrosis in CML is not uncommon and is associated with a poor prognosis. In cases unresponsive to treatment, tyrosine kinase mutation should be checked for drug resistance, second generation tyrosine kinase...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Serap Karaman, Mustafa Bilici, Ayşegül Ünüvar, Deniz Tuğcu, Gülşah Tanyıldız, Rumeysa Tuna Deveci, Gülçin Yegen, Şifa Şahin, Zeynep Karakaş
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/a1adf842c03041b58f9bd8dd0082a76e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!